Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1992
DOI: 10.1037/0021-843x.101.1.184
|View full text |Cite
|
Sign up to set email alerts
|

Clinical correlates of anhedonia and perceptual aberration in first-episode patients with schizophrenia and affective disorder.

Abstract: We wished to determine the specificity of smooth-pursuit eye tracking dysfunction to schizophrenia and the prevalences of dysfunction among functionally psychotic and normal individuals. Therefore, we investigated pursuit tracking in a large sample of psychotic patients, normal subjects, and first-degree relatives (N = 482). Patients were recruited as part of an epidemiological study of first-episode psychosis that used a broadly based referral network to identify all cases in a major metropolitan area over a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

14
56
1

Year Published

1995
1995
2014
2014

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 75 publications
(71 citation statements)
references
References 40 publications
(45 reference statements)
14
56
1
Order By: Relevance
“…In addition, PhysAnh demonstrated minimal covariation with clinical symptoms and remained persistently elevated even in a subsample of patients who achieved a fully remitted state, consistent with prior reports that PhysAnh is relatively independent of symptom state (Blanchard et al 1994;Katsanis et al 1992). Thus, anhedonia appears to be insensitive to clinical state fluctuations and present throughout the course of illness, similar to certain neurocognitive and neurophysiological deficits that have been identified as candidate endophenotypes for genetic studies of vulnerability to schizophrenia (Gur et al 2007).…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…In addition, PhysAnh demonstrated minimal covariation with clinical symptoms and remained persistently elevated even in a subsample of patients who achieved a fully remitted state, consistent with prior reports that PhysAnh is relatively independent of symptom state (Blanchard et al 1994;Katsanis et al 1992). Thus, anhedonia appears to be insensitive to clinical state fluctuations and present throughout the course of illness, similar to certain neurocognitive and neurophysiological deficits that have been identified as candidate endophenotypes for genetic studies of vulnerability to schizophrenia (Gur et al 2007).…”
Section: Discussionsupporting
confidence: 72%
“…That is, patients demonstrated abnormalities during symptomatic and asymptomatic states, but these were more deviant during symptomatic periods and significantly covaried with general psychotic, mood, and hostility symptoms across assessments (also see (Katsanis et al 1992). The key difference between stable and mediating vulnerability indicators is that the latter are believed to be more proximal in the chain of causal events that lead to symptom exacerbations than are stable vulnerability indicators.…”
Section: Discussionmentioning
confidence: 99%
“…Not surprisingly the Perceptual Aberration and Magical Ideation scales correlated significantly with almost all self-rated personality disorder dimensions when the questionnaires were filled out at the same point in time but the pattern of correlation changed when assessed with a time lag. Other researchers also discuss the impact of the presence of psychopathological symptoms and state variables on observed associations when the data is gathered simultaneously (Bailey et al, 1993;Katsanis, Iacono, Beiser, & Lacey, 1992;Merritt & Balogh, 1986). Therefore our conclusion is that a time-lagged assessment of such variables in a prospective study is needed.…”
Section: Methodological Considerations and Goal Of The Studymentioning
confidence: 83%
“…On the other hand, anhedonia measured by self-report measures (like the PAS and the SAS) seems to co-vary with clinical states in patients with depression, but reflects a trait in schizophrenia patients [35][36][37][38][39][40][41] . Anhedonia in schizophrenia, assessed by the PAS and SAS, has not been found to relate to clinical ratings of depression [20,35,[36][37][38] . Nonetheless, up to now in those studies, no scale originally designed to diagnose and evaluate depression in schizophrenia has been used.…”
Section: Discussionmentioning
confidence: 99%